Correction to “Lycorine Derivative Inhibits SARS-CoV-2 Replication by Reducing −1 Programmed Ribosomal Frameshifting via Targeting ZAP”

Abstract

Du T, Liu R, Zhang X, Shen L, Tang C, Wang J, Cheng Y, Yu W, Yin B, Lu S, Pan X, Peng X. Lycorine Derivative Inhibits SARS-CoV-2 Replication by Reducing −1 Programmed Ribosomal Frameshifting via Targeting ZAP. MedComm. 2026; DOI: 10.1002/mco2.70715

In the originally published version of this article, the statement indicating equal contribution among authors appeared incorrectly on the first page. The original statement read:

“Tingfu Du1, Ruixue Liu, Xintian Zhang these authors contributed equally to this work.”

This statement should have read:

“Tingfu Du, Ruixue Liu, Xintian Zhang and Longying Shen contributed equally to this work.”

We apologize for this error.

RIGHTS & PERMISSIONS

2026 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.